PuriCore logo — company profile

PuriCore

Founded 1997 United States Malvern, United States 51 employees Biotechnology, E-Commerce +1

General Information

Company Name PuriCore
Founded Year 1997
Location United States Malvern, United States +1
Employees 51
Industries Biotechnology, E-Commerce, Health Care
Social

Get notified when PuriCore moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PuriCore

PuriCore is an emerging biopharmaceutical company with a focus on leveraging proprietary technologies to protect and improve the health of adults and children. Founded in 1997, the company is listed on the London Stock Exchange and is based in Malvern, Pennsylvania. PuriCore's primary focus is the development of small molecule, immunomodulatory drug therapies in inflammatory diseases, with potential applications in dermatology, ophthalmology, and rare diseases. The company also operates in the Biotechnology, E-Commerce, and Health Care industries. PuriCore's commercial applications include products for both Supermarket Retail, available at www.steriloxfresh.com, and Health Sciences. In the Supermarket Retail sector, their products are utilized by leading supermarket retailers in the United States and Canada to enhance the freshness of fruit, vegetable, and flower displays. In the Health Sciences realm, the company offers a wound care solution for cleansing, debriding, and moisturizing chronic and acute wounds, such as diabetic ulcers and burns. As of now, PuriCore does not have disclosed last investment details or investors. For more information, visit their website at www.puricore.com.

Taxonomy: biopharmaceutical company, proprietary technologies, immunomodulatory drug therapies, inflammatory diseases, dermatology, ophthalmology, rare diseases, London Stock Exchange, Malvern, Pennsylvania, formulations, Supermarket Retail, Health Sciences, wound care solution, chronic wounds

No funding data available for PuriCore yet.

Get notified when PuriCore raises funding

PuriCore Alternatives & Competitors

PuriCore vs

Discovery, innovation and success in the biomedical sciences.

669 employees
Biotechnology, Health Care
PuriCore vs
Beacon Therapeutics
Beacon Therapeutics United Kingdom

Transforming Vision, Transforming Lives

Series C
95 employees
Biotechnology, Health Care
PuriCore vs

Bringing hope by expanding the frontiers of therapy

Seed
10 employees
Biotechnology

FAQ About PuriCore

PuriCore (AIM:PURI) is an emerging biopharmaceutical company passionately committed to leveraging its proprietary technologies to protect and improve the health of adults and children. In 2016, the Company began development of small molecule, immunomodulatory drug therapies in inflammatory diseases,...
PuriCore was founded in 1997.
PuriCore is headquartered in Malvern, United States.
PuriCore operates in the following industries: Biotechnology, E-Commerce, Health Care.
PuriCore has approximately 51 employees.
Top alternatives and competitors to PuriCore include Frederick National Laboratory for Cancer Research, Beacon Therapeutics, Find Therapeutics, Delpor, Inc., TransThera | 药捷安康. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PuriCore and Frederick National Laboratory for Cancer Research are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PuriCore and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy